QIAGEN N.V. (QGEN) is up 6.1% today. Here is some analysis on what might have caused this price move

Investing.com -- Qiagen NV (NYSE: QGEN) shares jumped over 7% on Tuesday following a Bloomberg report that Swedish private equity firm EQT AB is in advanced negotiations to acquire the European molecular diagnostics provider.

Qiagen (QGEN) shares jump on reports EQT and KKR bids over $50/share.

Q2 revenue was USD 535.04 million versus USD 527.50 million. Qiagen stock is EUR 42.48 on October 20

View QIAGEN NV QGEN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Qiagen stock costs EUR 41.66 on October 20, 2026, 0.99 percent above the Xetra close. Q2 revenue was

Revenue was USD 535.04 million versus USD 527.50 million. Qiagen stock costs EUR 41.14 on October 19

Second-quarter revenue reached USD 535.04 million and adjusted EPS USD 0.62. Qiagen stock costs EUR

The company serves science and health markets with research and clinical solutions. At Lang & Schwar

La empresa presta servicios a los mercados de la ciencia y la salud con soluciones clínicas y de investigación. En Lang & Schwar

QIAGEN amplió su cartera de pruebas de diagnóstico en EE. UU. tras la autorización de la FDA. El nuevo panel ofrece re

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Qiagen convenes a tuberculosis summit amid funding pressure. The October 13-16 event brings together